Krystal Biotech Inc (KRYS)
159.99
-1.61
(-1.00%)
USD |
NASDAQ |
May 31, 16:00
160.02
+0.02
(+0.02%)
After-Hours: 20:00
Krystal Biotech Free Cash Flow: -54.44M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -54.44M |
| December 31, 2023 | -100.60M |
| September 30, 2023 | -119.07M |
| June 30, 2023 | -129.81M |
| March 31, 2023 | -152.40M |
| December 31, 2022 | -153.55M |
| September 30, 2022 | -187.78M |
| June 30, 2022 | -182.29M |
| March 31, 2022 | -136.83M |
| December 31, 2021 | -116.27M |
| September 30, 2021 | -69.72M |
| June 30, 2021 | -52.44M |
| March 31, 2021 | -45.32M |
| Date | Value |
|---|---|
| December 31, 2020 | -40.93M |
| September 30, 2020 | -34.97M |
| June 30, 2020 | -29.46M |
| March 31, 2020 | -27.90M |
| December 31, 2019 | -25.09M |
| September 30, 2019 | -20.63M |
| June 30, 2019 | -17.96M |
| March 31, 2019 | -14.23M |
| December 31, 2018 | -11.68M |
| September 30, 2018 | -9.143M |
| June 30, 2018 | -7.481M |
| March 31, 2018 | -6.205M |
| December 31, 2017 | -4.10M |
Free Cash Flow Range, Past 5 Years
-187.78M
Minimum
Sep 2022
-17.96M
Maximum
Jun 2019
-84.87M
Average
-62.08M
Median
Free Cash Flow Benchmarks
| Axsome Therapeutics Inc | -193.34M |
| Madrigal Pharmaceuticals Inc | -391.12M |
| Alnylam Pharmaceuticals Inc | 127.82M |
| Catalyst Pharmaceuticals Inc | 81.59M |
| Cytokinetics Inc | -421.55M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 15.89M |
| Cash from Investing (Quarterly) | -25.98M |
| Cash from Financing (Quarterly) | 10.58M |
| Free Cash Flow Per Share (Quarterly) | 0.4994 |
| Free Cash Flow to Equity (Quarterly) | 14.63M |
| Free Cash Flow Yield | -1.20% |